Forge Biologics joins CIRM to manufacture AAV gene therapies

URLhttps://bioprocessintl.com/bioprocess-insider/deal
SourceBio Process Inernational
Date Published10/25/2023
Author NameShreeyashi Ojha

Additional Reshoring Information:

Company/Division name Forge Biologics and California Institute for Regen
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2023
Capital investment ($):120
City reshored to:Columbus
State(s) reshored to:OH
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredadeno-associated adenovirus (AAV), gene therapy
Find Reshoring Articles